ONECLINICAL INTEGRATED CLINICAL ENTERPRISE Trademark

Trademark Overview


On Monday, September 4, 2017, a trademark application was filed for ONECLINICAL INTEGRATED CLINICAL ENTERPRISE with the United States Patent and Trademark Office. The USPTO has given the ONECLINICAL INTEGRATED CLINICAL ENTERPRISE trademark a serial number of 87595180. The federal status of this trademark filing is PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED as of Tuesday, February 17, 2026. This trademark is owned by NAVITAS LIFE SCIENCES HOLDINGS LIMITED. The ONECLINICAL INTEGRATED CLINICAL ENTERPRISE trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

[ Computer software for use in administering clinical drug and medical device trials and submitting documents as part of clinical drug trial approval processes; Computer software for use in pharma and medical device product information management and to address regulatory requirements for pharma and medical device product information management; computer software platforms for use in pharma and medical device product information management and to address regulatory requirements for pharma and medical device product information management ]

scientific and technological services and research and design relating thereto, namely, scientific research, pharmaceutical drug development services, technology research in the field of pharmaceuticals, providing temporary use of on line non-downloadable computer software for submitting documents as part of for clinical drug trial approval processes and for use in pharma and medical device product information management and to address regulatory requirements for pharma and medical device product information management; advisory and consultancy services in the field of biotechnology; advisory services relating to science, namely, consulting services in the field of pharmacovigilance, biopharmaceutical and biotechnology research and consulting services relating to pharma and medical device product information management for pharma and medical device product information management; industrial analysis and research services, namely, industrial research in the field of medical devices; adv...
oneclinical integrated clinical enterprise

General Information


Serial Number87595180
Word MarkONECLINICAL INTEGRATED CLINICAL ENTERPRISE
Filing DateMonday, September 4, 2017
Status705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, February 17, 2026
Registration Number5718913
Registration DateTuesday, April 9, 2019
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 22, 2019

Trademark Statements


Goods and Services[ Computer software for use in administering clinical drug and medical device trials and submitting documents as part of clinical drug trial approval processes; Computer software for use in pharma and medical device product information management and to address regulatory requirements for pharma and medical device product information management; computer software platforms for use in pharma and medical device product information management and to address regulatory requirements for pharma and medical device product information management ]
Pseudo MarkONE CLINICAL INTEGRATED CLINICAL ENTERPRISE
Description of MarkThe mark consists of the term "ONECLINICAL" above the wording "INTEGRATED CLINICAL ENTERPRISE", with "ONE" in green, "CLINICAL" in blue and the words "INTEGRATED CLINICAL ENTERPRISE" in blue.
Goods and Servicesscientific and technological services and research and design relating thereto, namely, scientific research, pharmaceutical drug development services, technology research in the field of pharmaceuticals, providing temporary use of on line non-downloadable computer software for submitting documents as part of for clinical drug trial approval processes and for use in pharma and medical device product information management and to address regulatory requirements for pharma and medical device product information management; advisory and consultancy services in the field of biotechnology; advisory services relating to science, namely, consulting services in the field of pharmacovigilance, biopharmaceutical and biotechnology research and consulting services relating to pharma and medical device product information management for pharma and medical device product information management; industrial analysis and research services, namely, industrial research in the field of medical devices; advisory and consultancy services relating to computer networking applications software
Indication of Colors claimedThe color(s) green and blue is/are claimed as a feature of the mark.
NOT AVAILABLE"INTEGRATED CLINICAL ENTERPRISE"

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, February 17, 2026
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 11, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNAVITAS LIFE SCIENCES HOLDINGS LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPortsmouth, Hampshire PO64TY
GB

Party NameNAVITAS LIFE SCIENCES HOLDINGS LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPortsmouth, Hampshire PO64TY
GB

Party NameNAVITAS LIFE SCIENCES HOLDINGS LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPortsmouth, Hampshire PO64TY
GB

Trademark Events


Event DateEvent Description
Thursday, September 7, 2017NEW APPLICATION ENTERED
Monday, September 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 31, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, October 31, 2017TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, December 6, 2017ASSIGNED TO EXAMINER
Tuesday, December 12, 2017NON-FINAL ACTION WRITTEN
Tuesday, December 12, 2017NON-FINAL ACTION E-MAILED
Tuesday, December 12, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 1, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 14, 2018ASSIGNED TO LIE
Friday, June 15, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 15, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 28, 2018FINAL REFUSAL WRITTEN
Thursday, June 28, 2018FINAL REFUSAL E-MAILED
Thursday, June 28, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, December 17, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, December 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 17, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 22, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 9, 2025TEAS SECTION 8 & 15 RECEIVED
Thursday, August 14, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 14, 2025POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Tuesday, February 17, 2026TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, February 17, 2026REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, February 17, 2026NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED